Y. Mihara

The University of Tokyo

Papers

1

Total Citations

5

H-Index

1

About

Dr. Y. Mihara has made significant contributions to the field of hepatobiliary surgery, with a primary focus on advancing the surgical treatment of hepatocellular carcinoma (HCC). Their most-cited work, a comprehensive 2025 review on surgical approaches within multidisciplinary strategies, addresses the critical challenge of improving outcomes for the over 800,000 new HCC cases diagnosed globally each year. By critically evaluating traditional surgical criteria alongside emerging, integrated treatment paradigms, Dr. Mihara’s research provides a vital roadmap for clinicians navigating the complexities of modern HCC care. This work, with 5 citations, underscores their role in shaping evidence-based practice. Dr. Mihara’s scholarship is instrumental in bridging the gap between established surgical techniques and the dynamic landscape of multidisciplinary oncology, offering clear guidance for optimizing patient selection and therapeutic sequencing. Their ongoing dedication to refining surgical strategies ensures that their research remains a cornerstone for students and practitioners seeking to improve survival and quality of life for HCC patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Surgical treatment for hepatocellular carcinoma in era of multidisciplinary strategies
5 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: The University of Tokyo

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago